K Health, Inc.

K Health Inc. is a digital health company based in the US, specializing in AI-driven healthcare solutions that provide personalized primary care and mental health services to users through a comprehensive mobile application. Founded in 2016 in New York, US, K Health Inc. is dedicated to transforming healthcare delivery through its innovative technology.

The company has successfully completed 9 funding deals, with the most recent being a Series F round in July 2024, raising USD 50 mn from investors including Claure Group, Mangrove Capital Partners, Valor Equity Partners, and Atreides Management. Allon Bloch, one of the founders, serves as CEO and has a history of founding companies in the tech industry. K Health offers a suite of digital health solutions that leverage advanced artificial intelligence to provide personalized, data-driven care to patients. Their core product is the K Health app, which enables users to access virtual primary care services, urgent care, and mental health support 24/7.

The platform facilitates consultations with licensed clinicians who can diagnose conditions, prescribe medications, and develop treatment plans based on user-reported symptoms and health histories. This integrated approach aims to improve access to healthcare for a broad customer base, including individuals seeking immediate medical attention, chronic disease management, and mental health services. K Health operates primarily in the continental United States, excluding Alaska and Hawaii, and partners with leading healthcare systems such as Cedars-Sinai in California, Hartford HealthCare in Connecticut, and Hackensack Meridian Health in New Jersey, enhancing its service offerings through these collaborations. K Health generates revenue through partnerships with health systems and insurance providers, offering its services on a subscription basis or through insurance reimbursements.

This model allows users to access virtual care using their insurance plans, enabling a seamless payment process for services rendered on the K Health platform. For individuals without insurance, the app offers direct access to care for a fee, targeting a wide range of healthcare needs from primary care to urgent consultations. The company’s flagship offerings include features such as symptom checkers, AI-driven health assessments, and tailored treatment suggestions, which enhance user engagement and satisfaction. By fostering relationships with top health systems and utilizing a hybrid model of care delivery, K Health effectively positions itself to meet the evolving demands of the healthcare marketplace.

In July 2024, K Health Inc. raised USD 50 mn in Series F funding led by Claure Group. The company plans to utilize this funding to enhance its AI technology and drive growth in the US by integrating with other health systems. K Health aims to expand its offerings by developing new products and services, although specific upcoming releases have not been detailed.

The company is also looking to expand its geographic reach, focusing on new markets within the US to further increase its customer base and service capabilities.